SR One Capital Management — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

Addex Therapeutics Ltd.NASDAQ: ADXNApr 2023SEC filingmedium confidence

Geneva

Board seatJake Nunn· per SEC Form D · $3.7M raise · filed Apr 2023

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.